Bio-Techne Corporation continues to be a key player in the biotechnology sector, providing essential tools and solutions that support advancements in both research and clinical diagnostics. Despite facing competitive pressures, the company's diversified product portfolio and strong market position enable it to maintain a positive outlook.
Bio-Techne Corporation shows a solid overall performance in its fundamental metrics, signifying strong financial health and operational efficiency within its sector.
| Category | Score | |
|---|---|---|
| Discounted Cash Flow | 3 | |
| Return on Equity | 3 | |
| Return on Assets | 4 | |
| Debt to Equity | 3 | |
| Price to Earnings | 1 | |
| Price to Book | 2 |
The historical analysis reflects consistency in Bio-Techne Corporation's performance, with metrics largely stable over the recent period.
| Date | Overall | DCF | ROE | ROA | Debt/Equity | P/E | P/B |
|---|---|---|---|---|---|---|---|
| 2026-06-18 | 3 | 3 | 3 | 4 | 3 | 1 | 2 |
| Previous | 0 | 3 | 3 | 4 | 3 | 1 | 2 |
Analysts maintain an optimistic stance, showcasing a reasonable range of target prices reflecting growth potential within the market context.
| High | Low | Median | Consensus |
|---|---|---|---|
| 79 | 49 | 56 | Buy |
The sentiment from analysts remains largely positive, with a significant number of 'Buy' recommendations suggesting confidence in future performance.
| Recommendation | Count | |
|---|---|---|
| Strong Buy | 0 | |
| Buy | 18 | |
| Hold | 7 | |
| Sell | 0 | |
| Strong Sell | 0 |
Bio-Techne Corporation maintains a strong position in the biotechnology space, supported by consistent financial performance and a robust product strategy. Despite market challenges, its solid fundamentals and positive analyst sentiment suggest it could be a valuable long-term investment. However, potential investors should consider the inherent risks associated with the sector's volatility. Overall, the company's stability and growth trajectory make it a noteworthy stock to watch.
Don't leave your profits to chance. Historically, this stock follows specific seasonal patterns that institutional traders use to maximize returns.